Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres








Gamme d'année
1.
Neuroscience Bulletin ; (6): 1363-1374, 2023.
Article de Anglais | WPRIM | ID: wpr-1010626

RÉSUMÉ

Although sympathetic blockade is clinically used to treat pain, the underlying mechanisms remain unclear. We developed a localized microsympathectomy (mSYMPX), by cutting the grey rami entering the spinal nerves near the rodent lumbar dorsal root ganglia (DRG). In a chemotherapy-induced peripheral neuropathy model, mSYMPX attenuated pain behaviors via DRG macrophages and the anti-inflammatory actions of transforming growth factor-β (TGF-β) and its receptor TGF-βR1. Here, we examined the role of TGF-β in sympathetic-mediated radiculopathy produced by local inflammation of the DRG (LID). Mice showed mechanical hypersensitivity and transcriptional and protein upregulation of TGF-β1 and TGF-βR1 three days after LID. Microsympathectomy prevented mechanical hypersensitivity and further upregulated Tgfb1 and Tgfbr1. Intrathecal delivery of TGF-β1 rapidly relieved the LID-induced mechanical hypersensitivity, and TGF-βR1 antagonists rapidly unmasked the mechanical hypersensitivity after LID+mSYMPX. In situ hybridization showed that Tgfb1 was largely expressed in DRG macrophages, and Tgfbr1 in neurons. We suggest that TGF-β signaling is a general underlying mechanism of local sympathetic blockade.


Sujet(s)
Souris , Animaux , Récepteur de type I du facteur de croissance transformant bêta/métabolisme , Facteur de croissance transformant bêta/pharmacologie , Facteur de croissance transformant bêta-1/métabolisme , Hyperalgésie/métabolisme , Radiculopathie/métabolisme , Douleur/métabolisme , Analgésiques/pharmacologie , Ganglions sensitifs des nerfs spinaux/métabolisme
2.
Neuroscience Bulletin ; (6): 98-108, 2018.
Article de Anglais | WPRIM | ID: wpr-777072

RÉSUMÉ

Increasing evidence suggests that spinal microglia regulate pathological pain in males. In this study, we investigated the effects of several microglial and astroglial modulators on inflammatory and neuropathic pain following intrathecal injection in male and female mice. These modulators were the microglial inhibitors minocycline and ZVEID (a caspase-6 inhibitor) and the astroglial inhibitors L-α-aminoadipate (L-AA, an astroglial toxin) and carbenoxolone (a connexin 43 inhibitor), as well as U0126 (an ERK kinase inhibitor) and D-JNKI-1 (a c-Jun N-terminal kinase inhibitor). We found that spinal administration of minocycline or ZVEID, or Caspase6 deletion, reduced formalin-induced inflammatory and nerve injury-induced neuropathic pain primarily in male mice. In contrast, intrathecal L-AA reduced neuropathic pain but not inflammatory pain in both sexes. Intrathecal U0126 and D-JNKI-1 reduced neuropathic pain in both sexes. Nerve injury caused spinal upregulation of the astroglial markers GFAP and Connexin 43 in both sexes. Collectively, our data confirmed male-dominant microglial signaling but also revealed sex-independent astroglial signaling in the spinal cord in inflammatory and neuropathic pain.


Sujet(s)
Animaux , Femelle , Mâle , Souris , Acide 2-amino-adipique , Toxicité , Anti-inflammatoires , Utilisations thérapeutiques , Astrocytes , Anatomopathologie , Carbénoxolone , Pharmacologie , Caspase-6 , Métabolisme , Connexine 43 , Métabolisme , Modèles animaux de maladie humaine , Relation dose-effet des médicaments , Antienzymes , Pharmacologie , Protéine gliofibrillaire acide , Métabolisme , Souris transgéniques , Microglie , Anatomopathologie , Minocycline , Utilisations thérapeutiques , Névralgie , Traitement médicamenteux , Anatomopathologie , Mesure de la douleur , Phénylurées , Pharmacologie , Caractères sexuels , Moelle spinale , Anatomopathologie , Facteurs temps
3.
Neuroscience Bulletin ; (6): 4-12, 2018.
Article de Anglais | WPRIM | ID: wpr-777078

RÉSUMÉ

Voltage-gated sodium channels (Navs) play an important role in human pain sensation. However, the expression and role of Nav subtypes in native human sensory neurons are unclear. To address this issue, we obtained human dorsal root ganglion (hDRG) tissues from healthy donors. PCR analysis of seven DRG-expressed Nav subtypes revealed that the hDRG has higher expression of Nav1.7 (~50% of total Nav expression) and lower expression of Nav1.8 (~12%), whereas the mouse DRG has higher expression of Nav1.8 (~45%) and lower expression of Nav1.7 (~18%). To mimic Nav regulation in chronic pain, we treated hDRG neurons in primary cultures with paclitaxel (0.1-1 μmol/L) for 24 h. Paclitaxel increased the Nav1.7 but not Nav1.8 expression and also increased the transient Na currents and action potential firing frequency in small-diameter (<50 μm) hDRG neurons. Thus, the hDRG provides a translational model in which to study "human pain in a dish" and test new pain therapeutics.


Sujet(s)
Animaux , Femelle , Humains , Mâle , Souris , Potentiels d'action , Antinéoplasiques d'origine végétale , Pharmacologie , Relation dose-effet des médicaments , Stimulation électrique , Potentiels post-synaptiques excitateurs , Ganglions sensitifs des nerfs spinaux , Biologie cellulaire , Régulation de l'expression des gènes , Techniques in vitro , Génétique , Métabolisme , Neurones , Métabolisme , Paclitaxel , Pharmacologie , Techniques de patch-clamp , Spécificité d'espèce
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE